{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:06:36Z","timestamp":1793390796089,"version":"4.5.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,10,17]],"date-time":"2006-10-17T00:00:00Z","timestamp":1161043200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Vascular endothelial growth factor (VEGF) is a potent mediator of angiogenesis which has multiple effects in lung development and physiology. VEGF is expressed in several parts of the lung and the pleura while it has been shown that changes in its expression play a significant role in the pathophysiology of some of the most common respiratory disorders, such as acute lung injury, asthma, chronic obstructive pulmonary disease, obstructive sleep apnea, idiopathic pulmonary fibrosis, pulmonary hypertension, pleural disease, and lung cancer. However, the exact role of VEGF in the lung is not clear yet, as there is contradictory evidence that suggests either a protective or a harmful role. VEGF seems to interfere in a different manner, depending on its amount, the location, and the underlying pathologic process in lung tissue. The lack of VEGF in some disease entities may provide implications for its substitution, whereas its overexpression in other lung disorders has led to interventions for the attenuation of its action. Many efforts have been made in order to regulate the expression of VEGF and anti-VEGF antibodies are already in use for the management of lung cancer. Further research is still needed for the complete understanding of the exact role of VEGF in health and disease, in order to take advantage of its benefits and avoid its adverse effects. The scope of the present review is to summarize from a clinical point of view the changes in VEGF expression in several disorders of the respiratory system and focus on its diagnostic and therapeutic implications.<\/jats:p>","DOI":"10.1186\/1465-9921-7-128","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T00:01:09Z","timestamp":1161129669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?"],"prefix":"10.1186","volume":"7","author":[{"given":"Andriana I","family":"Papaioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kostikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagoula","family":"Kollia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,17]]},"reference":[{"issue":"2","key":"519_CR1_519","doi-asserted-by":"publisher","first-page":"L209","DOI":"10.1152\/ajplung.00185.2005","volume":"290","author":"NF Voelkel","year":"2006","unstructured":"Voelkel NF, Vandivier RW, Tuder RM: Vascular endothelial growth factor in the lung.\nAm J Physiol Lung Cell Mol Physiol 2006,290(2):L209\u201321.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"519_CR2_519","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0958-1669(00)00153-1","volume":"11","author":"N Ferrara","year":"2000","unstructured":"Ferrara N: VEGF: an update on biological and therapeutic aspects.\nCurr Opin Biotechnol 2000,11(6):617\u2013624.","journal-title":"Curr Opin Biotechnol"},{"issue":"11","key":"519_CR3_519","first-page":"3364","volume":"5","author":"BK Zebrowski","year":"1999","unstructured":"Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB Jr., Ellis LM: Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.\nClin Cancer Res 1999,5(11):3364\u20133368.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"519_CR4_519","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2222.2003.01576.x","volume":"33","author":"K Asai","year":"2003","unstructured":"Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J: Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients.\nClin Exp Allergy 2003,33(5):595\u2013599.","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"519_CR5_519","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors.\nNat Med 2003,9(6):669\u2013676.","journal-title":"Nat Med"},{"issue":"7","key":"519_CR6_519","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s001099900019","volume":"77","author":"N Ferrara","year":"1999","unstructured":"Ferrara N: Molecular and biological properties of vascular endothelial growth factor.\nJ Mol Med 1999,77(7):527\u2013543.","journal-title":"J Mol Med"},{"issue":"5","key":"519_CR7_519","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1152\/japplphysiol.00202.2004","volume":"97","author":"M Mura","year":"2004","unstructured":"Mura M, dos Santos CC, Stewart D, Liu M: Vascular endothelial growth factor and related molecules in acute lung injury.\nJ Appl Physiol 2004,97(5):1605\u20131617.","journal-title":"J Appl Physiol"},{"issue":"1","key":"519_CR8_519","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","volume":"13","author":"G Neufeld","year":"1999","unstructured":"Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors.\nFaseb J 1999,13(1):9\u201322.","journal-title":"Faseb J"},{"issue":"5","key":"519_CR9_519","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1074\/jbc.271.5.2746","volume":"271","author":"AP Levy","year":"1996","unstructured":"Levy AP, Levy NS, Goldberg MA: Post-transcriptional regulation of vascular endothelial growth factor by hypoxia.\nJ Biol Chem 1996,271(5):2746\u20132753.","journal-title":"J Biol Chem"},{"issue":"2","key":"519_CR10_519","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1091\/mbc.9.2.469","volume":"9","author":"KP Claffey","year":"1998","unstructured":"Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, Abrams KR, Lee SW, Detmar M: Identification of a human VPF\/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability.\nMol Biol Cell 1998,9(2):469\u2013481.","journal-title":"Mol Biol Cell"},{"issue":"10","key":"519_CR11_519","first-page":"4143","volume":"61","author":"Q Shi","year":"2001","unstructured":"Shi Q, Le X, Abbruzzese JL, Peng Z, Qian CN, Tang H, Xiong Q, Wang B, Li XC, Xie K: Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma.\nCancer Res 2001,61(10):4143\u20134154.","journal-title":"Cancer Res"},{"issue":"1","key":"519_CR12_519","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/01.CIR.92.1.11","volume":"92","author":"GT Stavri","year":"1995","unstructured":"Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD: Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia.\nCirculation 1995,92(1):11\u201314.","journal-title":"Circulation"},{"issue":"9","key":"519_CR13_519","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1101\/gad.13.9.1055","volume":"13","author":"NW Gale","year":"1999","unstructured":"Gale NW, Yancopoulos GD: Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.\nGenes Dev 1999,13(9):1055\u20131066.","journal-title":"Genes Dev"},{"issue":"6801","key":"519_CR14_519","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation.\nNature 2000,407(6801):242\u2013248.","journal-title":"Nature"},{"issue":"2","key":"519_CR15_519","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1165\/ajrcmb.27.2.4703","volume":"27","author":"C Galambos","year":"2002","unstructured":"Galambos C, Ng YS, Ali A, Noguchi A, Lovejoy S, D'Amore PA, DeMello DE: Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms.\nAm J Respir Cell Mol Biol 2002,27(2):194\u2013203.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"519_CR16_519","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1165\/ajrcmb.20.1.3251","volume":"20","author":"MJ Acarregui","year":"1999","unstructured":"Acarregui MJ, Penisten ST, Goss KL, Ramirez K, Snyder JM: Vascular endothelial growth factor gene expression in human fetal lung in vitro.\nAm J Respir Cell Mol Biol 1999,20(1):14\u201323.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"519_CR17_519","doi-asserted-by":"publisher","first-page":"L344","DOI":"10.1152\/ajplung.00291.2003","volume":"287","author":"JR Tang","year":"2004","unstructured":"Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, Abman SH: Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.\nAm J Physiol Lung Cell Mol Physiol 2004,287(2):L344\u201351.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"519_CR18_519","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nm721","volume":"8","author":"V Compernolle","year":"2002","unstructured":"Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P: Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice.\nNat Med 2002,8(7):702\u2013710.","journal-title":"Nat Med"},{"issue":"6","key":"519_CR19_519","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1165\/ajrcmb.22.6.3779","volume":"22","author":"RJ Kaner","year":"2000","unstructured":"Kaner RJ, Ladetto JV, Singh R, Fukuda N, Matthay MA, Crystal RG: Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema.\nAm J Respir Cell Mol Biol 2000,22(6):657\u2013664.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"519_CR20_519","doi-asserted-by":"publisher","first-page":"L539","DOI":"10.1152\/ajplung.00130.2003","volume":"286","author":"AS Kazi","year":"2004","unstructured":"Kazi AS, Lotfi S, Goncharova EA, Tliba O, Amrani Y, Krymskaya VP, Lazaar AL: Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent.\nAm J Physiol Lung Cell Mol Physiol 2004,286(3):L539\u201345.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"519_CR21_519","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF03401843","volume":"7","author":"RJ Kaner","year":"2001","unstructured":"Kaner RJ, Crystal RG: Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung.\nMol Med 2001,7(4):240\u2013246.","journal-title":"Mol Med"},{"issue":"2","key":"519_CR22_519","doi-asserted-by":"crossref","first-page":"L371","DOI":"10.1152\/ajplung.2000.279.2.L371","volume":"279","author":"S Boussat","year":"2000","unstructured":"Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, Adnot S, Maitre B: Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells.\nAm J Physiol Lung Cell Mol Physiol 2000,279(2):L371\u20138.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"519_CR23_519","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/00063198-200207000-00009","volume":"8","author":"CS Grove","year":"2002","unstructured":"Grove CS, Lee YC: Vascular endothelial growth factor: the key mediator in pleural effusion formation.\nCurr Opin Pulm Med 2002,8(4):294\u2013301.","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"519_CR24_519","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1136\/thx.54.8.707","volume":"54","author":"DR Thickett","year":"1999","unstructured":"Thickett DR, Armstrong L, Millar AB: Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions.\nThorax 1999,54(8):707\u2013710.","journal-title":"Thorax"},{"issue":"12","key":"519_CR25_519","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1164\/rccm.20110-040OC","volume":"165","author":"L Lavie","year":"2002","unstructured":"Lavie L, Kraiczi H, Hefetz A, Ghandour H, Perelman A, Hedner J, Lavie P: Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment.\nAm J Respir Crit Care Med 2002,165(12):1624\u20131628.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"519_CR26_519","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/thx.2004.034785","volume":"60","author":"AR Medford","year":"2005","unstructured":"Medford AR, Keen LJ, Bidwell JL, Millar AB: Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome.\nThorax 2005,60(3):244\u2013248.","journal-title":"Thorax"},{"issue":"9","key":"519_CR27_519","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1164\/ajrccm.164.9.2011071","volume":"164","author":"DR Thickett","year":"2001","unstructured":"Thickett DR, Armstrong L, Christie SJ, Millar AB: Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome.\nAm J Respir Crit Care Med 2001,164(9):1601\u20131605.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"519_CR28_519","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1164\/rccm.2105057","volume":"166","author":"DR Thickett","year":"2002","unstructured":"Thickett DR, Armstrong L, Millar AB: A role for vascular endothelial growth factor in acute and resolving lung injury.\nAm J Respir Crit Care Med 2002,166(10):1332\u20131337.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"519_CR29_519","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1183\/09031936.05.00106604","volume":"26","author":"LB Ware","year":"2005","unstructured":"Ware LB, Kaner RJ, Crystal RG, Schane R, Trivedi NN, McAuley D, Matthay MA: VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema.\nEur Respir J 2005,26(1):101\u2013105.","journal-title":"Eur Respir J"},{"issue":"6","key":"519_CR30_519","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1172\/JCI9674","volume":"106","author":"J Corne","year":"2000","unstructured":"Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, Waxman AB, Elias JA: IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.\nJ Clin Invest 2000,106(6):783\u2013791.","journal-title":"J Clin Invest"},{"issue":"10","key":"519_CR31_519","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1164\/rccm.200401-123OC","volume":"169","author":"H Kanazawa","year":"2004","unstructured":"Kanazawa H, Nomura S, Yoshikawa J: Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis.\nAm J Respir Crit Care Med 2004,169(10):1125\u20131130.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"519_CR32_519","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1067\/mai.2002.127797","volume":"110","author":"K Asai","year":"2002","unstructured":"Asai K, Kanazawa H, Otani K, Shiraishi S, Hirata K, Yoshikawa J: Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects.\nJ Allergy Clin Immunol 2002,110(4):571\u2013575.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"519_CR33_519","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/thorax.57.10.885","volume":"57","author":"H Kanazawa","year":"2002","unstructured":"Kanazawa H, Hirata K, Yoshikawa J: Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients.\nThorax 2002,57(10):885\u2013888.","journal-title":"Thorax"},{"issue":"11","key":"519_CR34_519","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1164\/rccm.200507-1105OC","volume":"173","author":"BN Feltis","year":"2006","unstructured":"Feltis BN, Wignarajah D, Zheng L, Ward C, Reid D, Harding R, Walters EH: Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma.\nAm J Respir Crit Care Med 2006,173(11):1201\u20131207.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"519_CR35_519","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1067\/mai.2001.115626","volume":"107","author":"M Hoshino","year":"2001","unstructured":"Hoshino M, Nakamura Y, Hamid QA: Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.\nJ Allergy Clin Immunol 2001,107(6):1034\u20131038.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"519_CR36_519","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1067\/mai.2001.111928","volume":"107","author":"M Hoshino","year":"2001","unstructured":"Hoshino M, Takahashi M, Aoike N: Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis.\nJ Allergy Clin Immunol 2001,107(2):295\u2013301.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"519_CR37_519","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/j.1365-2222.2005.02360.x","volume":"35","author":"A Chetta","year":"2005","unstructured":"Chetta A, Zanini A, Foresi A, D'Ippolito R, Tipa A, Castagnaro A, Baraldo S, Neri M, Saetta M, Olivieri D: Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma.\nClin Exp Allergy 2005,35(11):1437\u20131442.","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"519_CR38_519","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1067\/mai.2003.1455","volume":"111","author":"FQ Wen","year":"2003","unstructured":"Wen FQ, Liu X, Manda W, Terasaki Y, Kobayashi T, Abe S, Fang Q, Ertl R, Manouilova L, Rennard SI: TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids.\nJ Allergy Clin Immunol 2003,111(6):1307\u20131318.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"519_CR39_519","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0014-2999(01)01192-X","volume":"425","author":"N Bandi","year":"2001","unstructured":"Bandi N, Kompella UB: Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells.\nEur J Pharmacol 2001,425(2):109\u2013116.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"519_CR40_519","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jaci.2004.07.039","volume":"114","author":"KS Lee","year":"2004","unstructured":"Lee KS, Kim SR, Park HS, Jin GY, Lee YC: Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression.\nJ Allergy Clin Immunol 2004,114(5):1093\u20131099.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"519_CR41_519","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1378\/chest.125.5.1700","volume":"125","author":"H Kanazawa","year":"2004","unstructured":"Kanazawa H, Yoshikawa T, Hirata K, Yoshikawa J: Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients.\nChest 2004,125(5):1700\u20131705.","journal-title":"Chest"},{"issue":"7","key":"519_CR42_519","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.4049\/jimmunol.168.7.3595","volume":"168","author":"YC Lee","year":"2002","unstructured":"Lee YC, Kwak YG, Song CH: Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.\nJ Immunol 2002,168(7):3595\u20133600.","journal-title":"J Immunol"},{"issue":"2","key":"519_CR43_519","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/thx.2004.023986","volume":"60","author":"AR Kranenburg","year":"2005","unstructured":"Kranenburg AR, de Boer WI, Alagappan VK, Sterk PJ, Sharma HS: Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.\nThorax 2005,60(2):106\u2013113.","journal-title":"Thorax"},{"key":"519_CR44_519","doi-asserted-by":"publisher","first-page":"28s","DOI":"10.1183\/09031936.03.00000503","volume":"46","author":"NF Voelkel","year":"2003","unstructured":"Voelkel NF, Cool CD: Pulmonary vascular involvement in chronic obstructive pulmonary disease.\nEur Respir J Suppl 2003, 46:28s-32s.","journal-title":"Eur Respir J Suppl"},{"issue":"5","key":"519_CR45_519","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0002-9343(02)01562-0","volume":"114","author":"H Kanazawa","year":"2003","unstructured":"Kanazawa H, Asai K, Hirata K, Yoshikawa J: Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.\nAm J Med 2003,114(5):354\u2013358.","journal-title":"Am J Med"},{"issue":"11","key":"519_CR46_519","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1172\/JCI10259","volume":"106","author":"Y Kasahara","year":"2000","unstructured":"Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.\nJ Clin Invest 2000,106(11):1311\u20131319.","journal-title":"J Clin Invest"},{"issue":"1","key":"519_CR47_519","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1165\/rcmb.2002-0228OC","volume":"29","author":"RM Tuder","year":"2003","unstructured":"Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC: Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade.\nAm J Respir Cell Mol Biol 2003,29(1):88\u201397.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"519_CR48_519","volume-title":"Respir Med","author":"C Calabrese","year":"2006","unstructured":"Calabrese C, Bocchino V, Vatrella A, Marzo C, Guarino C, Mascitti S, Tranfa CM, Cazzola M, Micheli P, Caputi M, Marsico SA: Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction.\nRespir Med 2006."},{"issue":"5","key":"519_CR49_519","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1378\/chest.128.5.3191","volume":"128","author":"H Kanazawa","year":"2005","unstructured":"Kanazawa H, Yoshikawa J: Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD.\nChest 2005,128(5):3191\u20133197.","journal-title":"Chest"},{"issue":"2","key":"519_CR50_519","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/thx.2004.030544","volume":"60","author":"AJ Knox","year":"2005","unstructured":"Knox AJ, Stocks J, Sutcliffe A: Angiogenesis and vascular endothelial growth factor in COPD.\nThorax 2005,60(2):88\u201389.","journal-title":"Thorax"},{"issue":"13","key":"519_CR51_519","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1096\/fj.01-0338fje","volume":"15","author":"MR Abid","year":"2001","unstructured":"Abid MR, Tsai JC, Spokes KC, Deshpande SS, Irani K, Aird WC: Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism.\nFaseb J 2001,15(13):2548\u20132550.","journal-title":"Faseb J"},{"issue":"1","key":"519_CR52_519","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","volume":"163","author":"E Shahar","year":"2001","unstructured":"Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.\nAm J Respir Crit Care Med 2001,163(1):19\u201325.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"519_CR53_519","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1182\/blood.V98.4.1255","volume":"98","author":"S Imagawa","year":"2001","unstructured":"Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, Suzuki N, Yamamoto M, Nagasawa T: Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea--hypopnea syndrome.\nBlood 2001,98(4):1255\u20131257.","journal-title":"Blood"},{"issue":"8","key":"519_CR54_519","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2169\/internalmedicine.42.681","volume":"42","author":"S Teramoto","year":"2003","unstructured":"Teramoto S, Kume H, Yamamoto H, Ishii T, Miyashita A, Matsuse T, Akishita M, Toba K, Ouchi Y: Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome.\nIntern Med 2003,42(8):681\u2013685.","journal-title":"Intern Med"},{"issue":"1","key":"519_CR55_519","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1164\/ajrccm.165.1.2101062","volume":"165","author":"R Schulz","year":"2002","unstructured":"Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F: Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia.\nAm J Respir Crit Care Med 2002,165(1):67\u201370.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"519_CR56_519","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.rmed.2005.09.003","volume":"100","author":"AG Kaditis","year":"2006","unstructured":"Kaditis AG, Alexopoulos EI, Karadonta I, Kostadima E, Kiropoulos T, Gourgoulianis K, Syrogiannopoulos GA: Obstructive sleep-disordered breathing and plasma levels of vascular endothelial growth factor in children.\nRespir Med 2006,100(5):835\u2013840.","journal-title":"Respir Med"},{"issue":"20","key":"519_CR57_519","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/01.CIR.98.20.2108","volume":"98","author":"M Inoue","year":"1998","unstructured":"Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K: Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis.\nCirculation 1998,98(20):2108\u20132116.","journal-title":"Circulation"},{"issue":"1","key":"519_CR58_519","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/(SICI)1097-0185(19990101)254:1<61::AID-AR8>3.0.CO;2-D","volume":"254","author":"H Fehrenbach","year":"1999","unstructured":"Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M: Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy.\nAnat Rec 1999,254(1):61\u201373.","journal-title":"Anat Rec"},{"issue":"7","key":"519_CR59_519","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.2003.009860","volume":"59","author":"NR Simler","year":"2004","unstructured":"Simler NR, Brenchley PE, Horrocks AW, Greaves SM, Hasleton PS, Egan JJ: Angiogenic cytokines in patients with idiopathic interstitial pneumonia.\nThorax 2004,59(7):581\u2013585.","journal-title":"Thorax"},{"issue":"4","key":"519_CR60_519","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1067\/mlc.2000.105618","volume":"135","author":"KC Meyer","year":"2000","unstructured":"Meyer KC, Cardoni A, Xiang ZZ: Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.\nJ Lab Clin Med 2000,135(4):332\u2013338.","journal-title":"J Lab Clin Med"},{"issue":"3","key":"519_CR61_519","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1164\/rccm.2103112","volume":"166","author":"S Koyama","year":"2002","unstructured":"Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T: Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis.\nAm J Respir Crit Care Med 2002,166(3):382\u2013385.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"519_CR62_519","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1164\/rccm.200308-1151OC","volume":"170","author":"GP Cosgrove","year":"2004","unstructured":"Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, Schwarz MI, Cool CD, Worthen GS: Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.\nAm J Respir Crit Care Med 2004,170(3):242\u2013251.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"519_CR63_519","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1164\/rccm.200308-1111OC","volume":"169","author":"M Ebina","year":"2004","unstructured":"Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, Sasano H, Kondo T, Nukiwa T: Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis.\nAm J Respir Crit Care Med 2004,169(11):1203\u20131208.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"519_CR64_519","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/rccm.2403006","volume":"169","author":"EA Renzoni","year":"2004","unstructured":"Renzoni EA: Neovascularization in idiopathic pulmonary fibrosis: too much or too little?\nAm J Respir Crit Care Med 2004,169(11):1179\u20131180.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"519_CR65_519","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s004280050135","volume":"432","author":"E Tolnay","year":"1998","unstructured":"Tolnay E, Kuhnen C, Voss B, Wiethege T, Muller KM: Expression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis.\nVirchows Arch 1998,432(1):61\u201365.","journal-title":"Virchows Arch"},{"issue":"5","key":"519_CR66_519","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00408-003-1028-8","volume":"181","author":"M Sekiya","year":"2003","unstructured":"Sekiya M, Ohwada A, Miura K, Takahashi S, Fukuchi Y: Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis.\nLung 2003,181(5):259\u2013265.","journal-title":"Lung"},{"issue":"6","key":"519_CR67_519","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1378\/chest.125.6.2156","volume":"125","author":"F Alatas","year":"2004","unstructured":"Alatas F, Alatas O, Metintas M, Ozarslan A, Erginel S, Yildirim H: Vascular endothelial growth factor levels in active pulmonary tuberculosis.\nChest 2004,125(6):2156\u20132159.","journal-title":"Chest"},{"issue":"3 Pt 1","key":"519_CR68_519","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1164\/ajrccm.162.3.9911010","volume":"162","author":"W Matsuyama","year":"2000","unstructured":"Matsuyama W, Hashiguchi T, Matsumuro K, Iwami F, Hirotsu Y, Kawabata M, Arimura K, Osame M: Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis.\nAm J Respir Crit Care Med 2000,162(3 Pt 1):1120\u20131122.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"519_CR69_519","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1046\/j.1365-2567.2002.01395.x","volume":"106","author":"W Matsuyama","year":"2002","unstructured":"Matsuyama W, Kubota R, Hashiguchi T, Momi H, Kawabata M, Nakagawa M, Arimura K, Osame M: Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro.\nImmunology 2002,106(1):96\u2013101.","journal-title":"Immunology"},{"issue":"5","key":"519_CR70_519","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1159\/000050557","volume":"68","author":"Y Abe","year":"2001","unstructured":"Abe Y, Nakamura M, Oshika Y, Hatanaka H, Tokunaga T, Ohkubo Y, Hashizume T, Suzuki K, Fujino T: Serum levels of vascular endothelial growth factor and cavity formation in active pulmonary tuberculosis.\nRespiration 2001,68(5):496\u2013500.","journal-title":"Respiration"},{"issue":"6","key":"519_CR71_519","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1440-1827.2000.01068.x","volume":"50","author":"S Hirose","year":"2000","unstructured":"Hirose S, Hosoda Y, Furuya S, Otsuki T, Ikeda E: Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension.\nPathol Int 2000,50(6):472\u2013479.","journal-title":"Pathol Int"},{"issue":"5 Suppl","key":"519_CR72_519","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.1097\/00003246-200205001-00013","volume":"30","author":"NF Voelkel","year":"2002","unstructured":"Voelkel NF, Cool C, Taraceviene-Stewart L, Geraci MW, Yeager M, Bull T, Kasper M, Tuder RM: Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension.\nCrit Care Med 2002,30(5 Suppl):S251\u20136.","journal-title":"Crit Care Med"},{"issue":"6","key":"519_CR73_519","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1152\/japplphysiol.00083.2002","volume":"93","author":"M Fujita","year":"2002","unstructured":"Fujita M, Mason RJ, Cool C, Shannon JM, Hara N, Fagan KA: Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression.\nJ Appl Physiol 2002,93(6):2162\u20132170.","journal-title":"J Appl Physiol"},{"issue":"3","key":"519_CR74_519","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.953","volume":"195","author":"RM Tuder","year":"2001","unstructured":"Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, Yacoub M, Polak JM, Voelkel NF: Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.\nJ Pathol 2001,195(3):367\u2013374.","journal-title":"J Pathol"},{"issue":"1","key":"519_CR75_519","doi-asserted-by":"publisher","first-page":"L222","DOI":"10.1152\/ajplung.00388.2002","volume":"285","author":"E Mata-Greenwood","year":"2003","unstructured":"Mata-Greenwood E, Meyrick B, Soifer SJ, Fineman JR, Black SM: Expression of VEGF and its receptors Flt-1 and Flk-1\/KDR is altered in lambs with increased pulmonary blood flow and pulmonary hypertension.\nAm J Physiol Lung Cell Mol Physiol 2003,285(1):L222\u201331.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"519_CR76_519","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1096\/fj.00-0343com","volume":"15","author":"L Taraseviciene-Stewart","year":"2001","unstructured":"Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM: Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.\nFaseb J 2001,15(2):427\u2013438.","journal-title":"Faseb J"},{"issue":"18","key":"519_CR77_519","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1161\/hc4201.097838","volume":"104","author":"AI Campbell","year":"2001","unstructured":"Campbell AI, Zhao Y, Sandhu R, Stewart DJ: Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.\nCirculation 2001,104(18):2242\u20132248.","journal-title":"Circulation"},{"issue":"3","key":"519_CR78_519","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1442-200x.2005.02060.x","volume":"47","author":"F Gong","year":"2005","unstructured":"Gong F, Tang H, Lin Y, Gu W, Wang W, Kang M: Gene transfer of vascular endothelial growth factor reduces bleomycin-induced pulmonary hypertension in immature rabbits.\nPediatr Int 2005,47(3):242\u2013247.","journal-title":"Pediatr Int"},{"issue":"4 Pt 1","key":"519_CR79_519","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1164\/ajrccm.162.4.2003124","volume":"162","author":"S Eddahibi","year":"2000","unstructured":"Eddahibi S, Humbert M, Sediame S, Chouaid C, Partovian C, Maitre B, Teiger E, Rideau D, Simonneau G, Sitbon O, Adnot S: Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy.\nAm J Respir Crit Care Med 2000,162(4 Pt 1):1493\u20131499.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"519_CR80_519","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1378\/chest.118.6.1747","volume":"118","author":"D Cheng","year":"2000","unstructured":"Cheng D, Lee YC, Rogers JT, Perkett EA, Moyers JP, Rodriguez RM, Light RW: Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions.\nChest 2000,118(6):1747\u20131753.","journal-title":"Chest"},{"issue":"3","key":"519_CR81_519","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1378\/chest.116.3.760","volume":"116","author":"D Cheng","year":"1999","unstructured":"Cheng D, Rodriguez RM, Perkett EA, Rogers J, Bienvenu G, Lappalainen U, Light RW: Vascular endothelial growth factor in pleural fluid.\nChest 1999,116(3):760\u2013765.","journal-title":"Chest"},{"issue":"7","key":"519_CR82_519","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s002620050592","volume":"48","author":"H Yanagawa","year":"1999","unstructured":"Yanagawa H, Takeuchi E, Suzuki Y, Ohmoto Y, Bando H, Sone S: Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer.\nCancer Immunol Immunother 1999,48(7):396\u2013400.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"519_CR83_519","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1440-1843.2003.00529.x","volume":"9","author":"EA Hamed","year":"2004","unstructured":"Hamed EA, El-Noweihi AM, Mohamed AZ, Mahmoud A: Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.\nRespirology 2004,9(1):81\u201386.","journal-title":"Respirology"},{"issue":"3","key":"519_CR84_519","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3346\/jkms.2000.15.3.279","volume":"15","author":"SC Lim","year":"2000","unstructured":"Lim SC, Jung SI, Kim YC, Park KO: Vascular endothelial growth factor in malignant and tuberculous pleural effusions.\nJ Korean Med Sci 2000,15(3):279\u2013283.","journal-title":"J Korean Med Sci"},{"issue":"10","key":"519_CR85_519","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1053\/rmed.2002.1364","volume":"96","author":"H Momi","year":"2002","unstructured":"Momi H, Matsuyama W, Inoue K, Kawabata M, Arimura K, Fukunaga H, Osame M: Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.\nRespir Med 2002,96(10):817\u2013822.","journal-title":"Respir Med"},{"issue":"1","key":"519_CR86_519","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000065723","volume":"63","author":"O Ishimoto","year":"2002","unstructured":"Ishimoto O, Saijo Y, Narumi K, Kimura Y, Ebina M, Matsubara N, Asou N, Nakai Y, Nukiwa T: High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer.\nOncology 2002,63(1):70\u201375.","journal-title":"Oncology"},{"issue":"4","key":"519_CR87_519","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1183\/09031936.05.00037004","volume":"25","author":"U Sack","year":"2005","unstructured":"Sack U, Hoffmann M, Zhao XJ, Chan KS, Hui DS, Gosse H, Engelmann L, Schauer J, Emmrich F, Hoheisel G: Vascular endothelial growth factor in pleural effusions of different origin.\nEur Respir J 2005,25(4):600\u2013604.","journal-title":"Eur Respir J"},{"issue":"1","key":"519_CR88_519","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7","volume":"85","author":"A Kraft","year":"1999","unstructured":"Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marme D, Gastl G: Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.\nCancer 1999,85(1):178\u2013187.","journal-title":"Cancer"},{"issue":"1","key":"519_CR89_519","doi-asserted-by":"crossref","first-page":"L119","DOI":"10.1152\/ajplung.2001.281.1.L119","volume":"281","author":"KA Mohammed","year":"2001","unstructured":"Mohammed KA, Nasreen N, Hardwick J, Logie CS, Patterson CE, Antony VB: Bacterial induction of pleural mesothelial monolayer barrier dysfunction.\nAm J Physiol Lung Cell Mol Physiol 2001,281(1):L119\u201325.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"519_CR90_519","doi-asserted-by":"publisher","first-page":"468; author rep","DOI":"10.1378\/chest.128.1.468","volume":"128","author":"TS Kiropoulos","year":"2005","unstructured":"Kiropoulos TS, Kostikas K, Gourgoulianis KI: Vascular endothelial growth factor levels in pleural fluid and serum of patients with tuberculous pleural effusions.\nChest 2005,128(1):468; author reply 468\u20139.","journal-title":"Chest"},{"issue":"9","key":"519_CR91_519","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.clinbiochem.2004.03.012","volume":"37","author":"N Ilhan","year":"2004","unstructured":"Ilhan N, Ilhan N, Deveci F: Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types.\nClin Biochem 2004,37(9):840\u2013845.","journal-title":"Clin Biochem"},{"issue":"3","key":"519_CR92_519","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.lungcan.2004.02.021","volume":"45","author":"H Ishii","year":"2004","unstructured":"Ishii H, Yazawa T, Sato H, Suzuki T, Ikeda M, Hayashi Y, Takanashi Y, Kitamura H: Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).\nLung Cancer 2004,45(3):325\u2013337.","journal-title":"Lung Cancer"},{"issue":"1","key":"519_CR93_519","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.lungcan.2004.03.006","volume":"46","author":"S Tanno","year":"2004","unstructured":"Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K: Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.\nLung Cancer 2004,46(1):11\u201319.","journal-title":"Lung Cancer"},{"issue":"1","key":"519_CR94_519","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lungcan.2004.03.018","volume":"46","author":"V Ludovini","year":"2004","unstructured":"Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M: Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.\nLung Cancer 2004,46(1):77\u201385.","journal-title":"Lung Cancer"},{"issue":"4","key":"519_CR95_519","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1378\/chest.118.4.948","volume":"118","author":"W Matsuyama","year":"2000","unstructured":"Matsuyama W, Hashiguchi T, Mizoguchi A, Iwami F, Kawabata M, Arimura K, Osame M: Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer.\nChest 2000,118(4):948\u2013951.","journal-title":"Chest"},{"issue":"7","key":"519_CR96_519","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.rmed.2003.12.017","volume":"98","author":"A Kaya","year":"2004","unstructured":"Kaya A, Ciledag A, Gulbay BE, Poyraz BM, Celik G, Sen E, Savas H, Savas I: The prognostic significance of vascular endothelial growth factor levels in sera of non-small cell lung cancer patients.\nRespir Med 2004,98(7):632\u2013636.","journal-title":"Respir Med"},{"issue":"6","key":"519_CR97_519","first-page":"1517","volume":"26","author":"M Nishi","year":"2005","unstructured":"Nishi M, Abe Y, Tomii Y, Tsukamoto H, Kijima H, Yamazaki H, Ohnishi Y, Iwasaki M, Inoue H, Ueyama Y, Nakamura M: Cell binding isoforms of vascular endothelial growth factor-A (VEGF189) contribute to blood flow-distant metastasis of pulmonary adenocarcinoma.\nInt J Oncol 2005,26(6):1517\u20131524.","journal-title":"Int J Oncol"},{"key":"519_CR98_519","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2407-5-128","volume":"5","author":"R Cressey","year":"2005","unstructured":"Cressey R, Wattananupong O, Lertprasertsuke N, Vinitketkumnuen U: Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.\nBMC Cancer 2005, 5:128.","journal-title":"BMC Cancer"},{"issue":"2","key":"519_CR99_519","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1440-1843.2002.00376.x","volume":"7","author":"I Kishiro","year":"2002","unstructured":"Kishiro I, Kato S, Fuse D, Yoshida T, Machida S, Kaneko N: Clinical significance of vascular endothelial growth factor in patients with primary lung cancer.\nRespirology 2002,7(2):93\u201398.","journal-title":"Respirology"},{"issue":"1","key":"519_CR100_519","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00408-004-2521-4","volume":"183","author":"Y Shimanuki","year":"2005","unstructured":"Shimanuki Y, Takahashi K, Cui R, Hori S, Takahashi F, Miyamoto H, Fukurchi Y: Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.\nLung 2005,183(1):29\u201342.","journal-title":"Lung"},{"issue":"4","key":"519_CR101_519","first-page":"481","volume":"18","author":"NJ Agnantis","year":"2004","unstructured":"Agnantis NJ, Goussia AC, Batistatou A, Stefanou D: Tumor markers in cancer patients. an update of their prognostic significance. Part II.\nIn Vivo 2004,18(4):481\u2013488.","journal-title":"In Vivo"},{"issue":"3","key":"519_CR102_519","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1081\/CNV-200055949","volume":"23","author":"AZ Dudek","year":"2005","unstructured":"Dudek AZ, Mahaseth H: Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival.\nCancer Invest 2005,23(3):193\u2013200.","journal-title":"Cancer Invest"},{"issue":"1","key":"519_CR103_519","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.lungcan.2005.05.011","volume":"50","author":"E Laack","year":"2005","unstructured":"Laack E, Scheffler A, Burkholder I, Boeters I, Andritzky B, Schuch G, Gorn M, Vohwinkel G, Edler L, Fiedler W, Hossfeld DK: Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).\nLung Cancer 2005,50(1):51\u201358.","journal-title":"Lung Cancer"},{"key":"519_CR104_519","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/S0169-5002(05)81570-3","volume":"50 Suppl 2","author":"T Lynch Jr.","year":"2005","unstructured":"Lynch T Jr., Kim E: Optimizing chemotherapy and targeted agent combinations in NSCLC.\nLung Cancer 2005, 50 Suppl 2:S25\u201332.","journal-title":"Lung Cancer"},{"issue":"6","key":"519_CR105_519","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1164\/ajrccm.161.6.9905022","volume":"161","author":"SA McColley","year":"2000","unstructured":"McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE: Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.\nAm J Respir Crit Care Med 2000,161(6):1877\u20131880.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"519_CR106_519","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1183\/09031936.03.00085903","volume":"21","author":"Y Nishigaki","year":"2003","unstructured":"Nishigaki Y, Fujiuchi S, Yamazaki Y, Matsumoto H, Takeda A, Fujita Y, Okamoto K, Fujikane T, Shimizu T, Kikuchi K: Increased vascular endothelial growth factor in acute eosinophilic pneumonia.\nEur Respir J 2003,21(5):774\u2013778.","journal-title":"Eur Respir J"},{"issue":"4","key":"519_CR107_519","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/13813450312331337612","volume":"111","author":"C Navarro","year":"2003","unstructured":"Navarro C, Ruiz V, Gaxiola M, Carrillo G, Selman M: Angiogenesis in hypersensitivity pneumonitis.\nArch Physiol Biochem 2003,111(4):365\u2013368.","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"519_CR108_519","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10147-006-0568-3","volume":"11","author":"S Yano","year":"2006","unstructured":"Yano S, Matsumori Y, Ikuta K, Ogino H, Doljinsuren T, Sone S: Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer.\nInt J Clin Oncol 2006,11(2):73\u201381.","journal-title":"Int J Clin Oncol"},{"issue":"12 Pt 2","key":"519_CR109_519","doi-asserted-by":"publisher","first-page":"4258s","DOI":"10.1158\/1078-0432.CCR-040023","volume":"10","author":"AB Sandler","year":"2004","unstructured":"Sandler AB, Johnson DH, Herbst RS: Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer.\nClin Cancer Res 2004,10(12 Pt 2):4258s-4262s.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"519_CR110_519","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/ncponc0026","volume":"1","author":"DJ Kerr","year":"2004","unstructured":"Kerr DJ: Targeting angiogenesis in cancer: clinical development of bevacizumab.\nNat Clin Pract Oncol 2004,1(1):39\u201343.","journal-title":"Nat Clin Pract Oncol"},{"key":"519_CR111_519","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S0169-5002(03)00144-2","volume":"41 Suppl 1","author":"FA Shepherd","year":"2003","unstructured":"Shepherd FA, Sridhar SS: Angiogenesis inhibitors under study for the treatment of lung cancer.\nLung Cancer 2003, 41 Suppl 1:S63\u201372.","journal-title":"Lung Cancer"},{"issue":"3","key":"519_CR112_519","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.lungcan.2004.05.005","volume":"46","author":"J Litz","year":"2004","unstructured":"Litz J, Sakuntala Warshamana-Greene G, Sulanke G, Lipson KE, Krystal GW: The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.\nLung Cancer 2004,46(3):283\u2013291.","journal-title":"Lung Cancer"},{"issue":"3","key":"519_CR113_519","first-page":"957","volume":"6","author":"S Yano","year":"2000","unstructured":"Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ: Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.\nClin Cancer Res 2000,6(3):957\u2013965.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"519_CR114_519","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1378\/chest.128.3.1790","volume":"128","author":"YB Guo","year":"2005","unstructured":"Guo YB, Kalomenidis I, Hawthorne M, Parman KS, Lane KB, Light RW: Pleurodesis is inhibited by anti-vascular endothelial growth factor antibody.\nChest 2005,128(3):1790\u20131797.","journal-title":"Chest"},{"issue":"2","key":"519_CR115_519","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/thx.2004.031500","volume":"60","author":"AG Richter","year":"2005","unstructured":"Richter AG, Maughan EO, Perkins GD, Nathani N, Thickett DR: VEGF levels in pulmonary fibrosis.\nThorax 2005,60(2):171.","journal-title":"Thorax"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-7-128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-7-128\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-7-128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-7-128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:39:18Z","timestamp":1630456758000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-7-128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,17]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-7-128","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,17]]},"assertion":[{"value":"21 June 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"128"}}